Download PDF
Thromb Haemost 1997; 78(01): 427-433
DOI: 10.1055/s-0038-1657564
PLENARY LECTURE – Wright-Schulte Lecture
Schattauer GmbH Stuttgart

Coagulation Factor V: An Old Star Shines Again

Jan Rosing
Department of Biochemistry, Cardiovascular Research, Maastricht University, the Netherlands
,
Guido Tans
Department of Biochemistry, Cardiovascular Research, Maastricht University, the Netherlands
› Author Affiliations
Further Information

Publication History

Publication Date:
12 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Nolf P. Contribution á l’étude de la coagulation du sang. Les facteurs promordiaux, leurs origine. Arch Int Physiol 1908; 06: 1-72
    PubMedGoogle Scholar
  • 2 Owren PA. The coagulation of blood. Investigations on a new clotting factor. Act Med Scand 1947; Suppl 128: 194-327
    PubMedGoogle Scholar
  • 3 Ware AG, Murphy RC, Seegers WH. The function of Ac-globulin in blood clotting. Science 106 1947; 618-619
    PubMedGoogle Scholar
  • 4 Kisiel W, Canfield WM, Ericsson LH, Davie EW. Anticoagulant properties of bovine plasma protein C following activation by thrombin. Biochemistry 1977; 16: 5824-5831
    CrossrefPubMedGoogle Scholar
  • 5 Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-1008
    CrossrefPubMedGoogle Scholar
  • 6 Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, De RondeH, Van derVelden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
    CrossrefPubMedGoogle Scholar
  • 7 Greengard JS, Sun X, Xu X, Fernandez JA, Griffin JH, Evatt B. Activated protein C resistance caused by Arg506Gln mutation in factor Va. Lancet 1994; 343: 1361-1362
    PubMedGoogle Scholar
  • 8 Voorberg J, Roelse JC, Koopman R, Buller HR, Berends F, Ten CateJW, Mertens K, Van MourikJA. Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V. Lancet 1994; 343: 1535-1536
    CrossrefPubMedGoogle Scholar
  • 9 Zoller B, Dahlbäck B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 1994; 343: 1536-1538
    CrossrefPubMedGoogle Scholar
  • 10 Esmon CT. The subunit structure of thrombin-activated factor V. Isolation of activated factor V, separation of subunits and reconstitution of biological activity. J Biol Chem 1979; 254: 964-973
    PubMedGoogle Scholar
  • 11 Nesheim ME, Myrmel KH, Hibbard L, Mann KG. Isolation and characterization of single chain bovine factor V. J Biol Chem 1979; 254: 508-517
    PubMedGoogle Scholar
  • 12 Dahlbäck B. Human coagulation factor V purification and thrombin-catalyzed activation. J Clin Invest 1980; 66: 583-591
    CrossrefPubMedGoogle Scholar
  • 13 Kane WH, Majerus PW. Purification and characterization of human coagulation factor V. J Biol Chem 1981; 256: 1002-1007
    PubMedGoogle Scholar
  • 14 Rosing J, Bakker HM, Thomassen MCLGD, Hemker HC, Tans G. Characterization of two forms of human factor Va with different cofactor activities. J Biol Chem 1993; 268: 21130-21136
    PubMedGoogle Scholar
  • 15 Keller FG, Ortel TL, Quinn-Allen MA, Kane WH. Thrombin- catalyzed activation of recombinant human factor V. Biochemistry 1995; 34: 4118-4124
    CrossrefPubMedGoogle Scholar
  • 16 Marquette KA, Pittman DD, Kaufman RJ. The factor V B-domain provides two functions to facilitate thrombin cleavage and release of the light chain. Blood 1995; 86: 3026-3034
    PubMedGoogle Scholar
  • 17 Ortel TL, Devore CarterD, Quinn AllenM, Kane WH. Deletion analysis of recombinant human factor V. Evidence for a phosphatidylserine binding site in the second C-type domain. J Biol Chem 1992; 267: 4189-4198
    PubMedGoogle Scholar
  • 18 Nesheim ME, Taswell JB, Mann KG. The contribution of bovine factor V and factor Va to the activity of prothrombinase. J Biol Chem 1979; 254: 10952-10962
    PubMedGoogle Scholar
  • 19 Guinto ER, Esmon CT, Mann KG, MacGillivray RT. The complete cDNA sequence of bovine coagulation factor V. J Biol Chem 1992; 267: 2971-2978
    PubMedGoogle Scholar
  • 20 Jenny RJ, Pittman DD, Toole JJ, Kriz RW, Aldape RA, Hewick RM, Kaufman RJ, Mann KG. Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci USA 1987; 84: 4846-4850
    CrossrefPubMedGoogle Scholar
  • 21 Nesheim ME, Mann KG. Thrombin-catalyzed activation of single chain bovine factor V. J Biol Chem 1979; 254: 1326-1334
    PubMedGoogle Scholar
  • 22 Monkovic D, Tracy P. Activation of human factor V by factor Xa and thrombin. Biochemistry 1990; 29: 1118-1128
    CrossrefPubMedGoogle Scholar
  • 23 Suzuki K, Dahlbäck B, Stenflo J. Thrombin-catalyzed activation of human coagulation factor V. J Biol Chem 1982; 257: 6556-664
    PubMedGoogle Scholar
  • 24 Foster WB, Nesheim ME, Mann KG. The factor Xa-catalyzed activation of factor V. J Biol Chem 1983; 258: 13970-13977
    PubMedGoogle Scholar
  • 25 Tans G, Nicolaes GA, Thomassen MCLGD, Hemker HC, van ZonneveldAJ, Pannekoek H, Rosing J. Activation of human factor V by meizothrombin. J Biol Chem 1994; 269: 15969-15972
    PubMedGoogle Scholar
  • 26 Rosing J, Zwaal RFA, Tans G. Formation of meizothrombin as intermediate in factor Xa-catalyzed prothrombin activation. J Biol Chem 1986; 261: 4224-4228
    PubMedGoogle Scholar
  • 27 Krishnaswamy S, Mann KG, Nesheim ME. The prothrombinase-catalyzed activation of prothrombin proceeds through the intermediate meizothrombin in an ordered, sequential reaction. J Biol Chem 1986; 261: 8977-8984
    PubMedGoogle Scholar
  • 28 Guinto ER, Esmon CT. Formation of a calcium-binding site on bovine activated factor V following recombination of the isolated subunits. J Biol Chem 1982; 257: 10038-10043
    PubMedGoogle Scholar
  • 29 Tracy PB, Eide LL, Bowie EJ, Mann KG. Radioimmunoassay of factor V in human plasma and platelets. Blood 1982; 60: 59-63
    PubMedGoogle Scholar
  • 30 Viskup RW, Tracy PB, Mann KG. The isolation of human platelet factor V. Blood 1987; 69: 1188-1195
    PubMedGoogle Scholar
  • 31 Bloom JW, Nesheim ME, Mann KG. Phospholipid-binding properties of bovine factor V and factor Va. Biochemistry 1979; 18: 4419-4425
    CrossrefPubMedGoogle Scholar
  • 32 Pusey ML, Mayer LD, Wei GJ, Bloomfield VA, Nelsestuen GL. Kinetic and hydrodynamic analysis of blood clotting factor V-membrane binding. Biochemistry 1982; 21: 5262-5269
    CrossrefPubMedGoogle Scholar
  • 33 van deWaart P, Bruls H, Hemker HC, Lindhout T. Interaction of bovine blood clotting factor Va and its subunits with phospholipid vesicles. Biochemistry 1983; 22: 2427-2432
    CrossrefPubMedGoogle Scholar
  • 34 Higgins DL, Mann KG. The interaction of bovine factor V and factor V-derived peptides with phospholipid vesicles. J Biol Chem 1983; 258: 6503-6508
    PubMedGoogle Scholar
  • 35 Kalafatis M, Rand MD, Mann KG. Factor Va-membrane interaction is mediated by two regions located on the light chain of the cofactor. Biochemistry 1994; 33: 486-493
    CrossrefPubMedGoogle Scholar
  • 36 Kalafatis M, Jenny RJ, Mann KG. Identification and characterization of a phospholipid-binding site of bovine factor Va. J Biol Chem 1990; 265: 21580-21589
    PubMedGoogle Scholar
  • 37 Ortel TL, Yoo L, Quinn-Allen MA, Kane WH. Partial glycosylation at asparagine-2181 of the second C-type domain of human factor V is the structural basis of the light chain doublet. Blood 1994; 84 no. 10 suppl. 1-387 a
    PubMedGoogle Scholar
  • 38 Boskovic DS, Giles AR, Nesheim ME. Studies of the role of Va in the factor Xa-catalyzed activation of prothrombin, fragment 1 2-prethrombin-2, and dansyl-L-glutamyl-glycyl-L-arginine-meizo-thrombin in the absence of phospholipid. J Biol Chem 1990; 265: 10497-10505
    PubMedGoogle Scholar
  • 39 Pryzdial EL, Mann KG. The association of coagulation factor Xa and factor Va. J Biol Chem 1991; 266: 8969-8977
    PubMedGoogle Scholar
  • 40 Nesheim ME, Eid S, Mann KG. Assembly of the prothrombinase complex in the absence of prothrombin. J Biol Chem 1981; 256: 9874-9882
    PubMedGoogle Scholar
  • 41 Lindhout T, Govers RiemslagJWP, van deWaart P, Hemker HC, Rosing J. Factor Va- factor Xa interaction. Effects of phospholipid vesicles of varying composition. Biochemistry 1982; 21: 5494-5502
    CrossrefPubMedGoogle Scholar
  • 42 Krishnaswamy S. Prothrombinase complex assembly contribution of protein-protein and protein-membrane interactions toward complex formation. J Biol Chem 1990; 07: 3708-3718
    PubMedGoogle Scholar
  • 43 Nelsestuen GL, Broderius M. Interactions of prothrombin and blood-clotting factor X with membranes varying composition. Biochemistry 1977; 16: 4172-4177
    CrossrefPubMedGoogle Scholar
  • 44 Annamalai AE, Rao AK, Chiu HC, Wang D, Dutta RoyAK, Walsh PN, Colman RW. Epitope mapping of functional domains of human factor Va with human and murine monoclonal antibodies. Evidence for the interaction of heavy chain with factor Xa and calcium. Blood 1987; 70: 139-146
    PubMedGoogle Scholar
  • 45 Kalafatis M, Xue J, Lawler CM, Mann KG. Contribution of the heavy and light chains of factor Va to the interaction with factor Xa. Biochemistry 1994; 33: 6538-6545
    CrossrefPubMedGoogle Scholar
  • 46 Tucker MM, Foster WB, Katzmann JA, Mann KG. A monoclonal antibody which inhibits the factor Va:factor Xa interaction. J Biol Chem 1983; 258: 1210-1214
    PubMedGoogle Scholar
  • 47 Guinto ER, Esmon CT. Loss of prothrombin and of factor Xa- fiactor Va interactions upon inactivation of factor Va by activated protein C. J Biol Chem 1984; 259: 13986-13992
    PubMedGoogle Scholar
  • 48 Nicolaes GA, Tans G, Thomassen MCLGD, Hemker HC, Pabinger I, Varadi K, Schwarz HP, Rosing J. Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem 1995; 270: 21158-21166
    CrossrefPubMedGoogle Scholar
  • 49 Bakker HM, Tans G, Thomassen MCLGD, Yukelson LY, Ebberink R, Hemker HC, Rosing J. Functional properties of human factor Va lacking the Asp683- Arg709 domain of the heavy chain. J Biol Chem 1994; 269: 20662-20667
    CrossrefPubMedGoogle Scholar
  • 50 Esmon CT, Jackson CM. Conversion of prothrombin to thrombin. IV. The function of the fragment 2 region during activation in the presence of factor V. J Biol Chem 1974; 249: 7791-7797
    PubMedGoogle Scholar
  • 51 Kotkow KJ, Deitcher SR, Furie B, Furie BC. The second kringle domain of prothrombin promotes factor Va- mediated prothrombin activation by prothrombinase. J Biol Chem 1995; 270: 4551-4557
    CrossrefPubMedGoogle Scholar
  • 52 van deWaart P, Hemker HC, Lindhout T. Interaction of prothrombin with factor Va-phospholipid complexes. Biochemistry 1984; 23: 2838-2842
    CrossrefPubMedGoogle Scholar
  • 53 Luckow EA, Lyons DA, Ridgeway TM, Esmon CT, Laue TM. Interaction of clotting factor V heavy chain with prothrombin and prethrombin 1 and role of activated protein C in regulating this interaction:analysis by analytical ultracentrifiigation. Biochemistry 1989; 28: 2348-2354
    CrossrefPubMedGoogle Scholar
  • 54 Rijn vanJLML, Govers RiemslagJWP, Zwaal RFA, Rosing J. Kinetic studies of prothrombin activation-. Effect of factor Va and phospholipids on the formation of the enzyme-substrate complex. Biochemistry 1984; 23: 4557-4563
    CrossrefPubMedGoogle Scholar
  • 55 Krishnaswamy S, Williams EB, Mann KG. The binding of activated protein C to factors V and Va. J Biol Chem 1986; 261: 9684-9693
    PubMedGoogle Scholar
  • 56 Walker FJ, Scandella D, Fay PJ. Identification of the binding site for activated protein C on the light chain of factors V and VIII. J Biol Chem 1990; 265: 1484-1489
    PubMedGoogle Scholar
  • 57 Heeb MJ, Kojima Y, Hackeng TM, Griffin JH. Binding sites for blood coagulation factor Xa and protein S involving residues 49-506 in factor Va. Protein Science 1996; 05: 1883-1889
    CrossrefPubMedGoogle Scholar
  • 58 Esmon CT, Owen WG, Jackson CM. A plausible mechanism for prothrombin activation by factor Xa, factor Va, phospholipid and calcium ions. J Biol Chem 1974; 249: 8045-8047
    PubMedGoogle Scholar
  • 59 Rosing J, Tans G, Govers RiemslagJWP, Zwaal RFA, Hemker HC. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem 1980; 255: 274-283
    PubMedGoogle Scholar
  • 60 Suttie JW, Jackson CM. Prothrombin structure, activation and biosynthesis. Physiol Rev 1977; 57: 1-70
    CrossrefPubMedGoogle Scholar
  • 61 Husten EJ, Esmon CT, Johnson AE. The active site of blood coagulation factor Xa. Its distance from the phospholipid surface and its conformational sensitivity to components of the prothrombinase complex. J Biol Chem 1987; 262: 12953-12961
    PubMedGoogle Scholar
  • 62 Krishnaswamy S, Vlasuk GP, Bergum PW. Assembly of the prothrombinase complex enhances the inhibition of bovine factor Xaby tick anticoagulant peptide. Biochemistry 1994; 33: 7897-7907
    CrossrefPubMedGoogle Scholar
  • 63 Mammen EF, Thomas WR, Seegers WH. Activation of purified prothrombin to autoprothrombin I or autoprothrombin II (platelet cofactor II or autoprothrombin II-A). Thromb Diathes Haemorrh 1960; 05: 218-250
    PubMedGoogle Scholar
  • 64 Stenflo J. A new vitamin K-dependent protein. Purification from bovine plasma and preliminary characterization. J Biol Chem 1976; 251: 355-363
    PubMedGoogle Scholar
  • 65 Walker FJ. Regulation of activated protein C by a new protein A possible function for bovine protein S. J Biol Chem 1980; 255: 5521-5524
    PubMedGoogle Scholar
  • 66 Walker FJ. Regulation of activated protein C by protein S. The role of phospholipid in factor Va inactivation. J Biol Chem 1981; 256: 11128-11131
    PubMedGoogle Scholar
  • 67 Solymoss S, Tucker MM, Tracy PB. Kinetics of inactivation of membrane-bound factor Va by activated protein C. J Biol Chem 1988; 263: 14884-14890
    PubMedGoogle Scholar
  • 68 Bakker HM, Tans G, Janssen ClaessenT, Thomassen MCLGD, Hemker HC, Griffin JH, Rosing J. The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C. Eur J Biochem 1992; 208: 171-178
    CrossrefPubMedGoogle Scholar
  • 69 Smirnov MD, Esmon CT. Phosphatidylethanolamine incorporation into vesicles selectively enhances factor Va inactivation by activated protein C. J Biol Chem 1994; 269: 816-819
    PubMedGoogle Scholar
  • 70 Tans G, Rosing J, Thomassen MCLGD, Heeb MJ, Zwaal RF, Griffin JH. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood 1991; 77: 2641-2648
    PubMedGoogle Scholar
  • 71 Suzuki K, Stenflo J, Dahlbäck B, Teodorsson B. Inactivation of human coagulation factor V by activated protein C. J Biol Chem 1983; 258: 1914-1920
    PubMedGoogle Scholar
  • 72 Walker FJ, Sexton PW, Esmon CT. The inhibition of blood coagulation by activated protein C through the selective inactivation of activated factor V. Biochim Biophys acta 1979; 571: 333-342
    CrossrefPubMedGoogle Scholar
  • 73 van deWaart P, Bruls H, Hemker HC, Lindhout T. Functional properties of factor Va subunits after proteolytic alterations by activated protein C. Biochim Biophys Acta 1984; 799: 38-44
    CrossrefPubMedGoogle Scholar
  • 74 Odegaard B, Mann K. Proteolysis of factor Va by factor Xa and activated protein C. J Biol Chem 1987; 262: 11233-11238
    PubMedGoogle Scholar
  • 75 Kalafatis M, Mann KG. Role of the membrane in the inactivation of factor Va by activated protein C. J Biol Chem 1993; 268: 27246-27257
    PubMedGoogle Scholar
  • 76 Kalafatis M, Rand MD, Mann KG. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem 1994; 269: 31869-31880
    PubMedGoogle Scholar
  • 77 Kalafatis M, Bertina RM, Rand MD, Mann KG. Characterization of the molecular defect in factor VR506Q. J Biol Chem 1995; 270: 4053-4057
    CrossrefPubMedGoogle Scholar
  • 78 Heeb MJ, Kojima Y, Greengard JS, Griffin JH. Activated protein C resistance:molecular mechanisms based on studies using purified Gln506-factor V. Blood 1995; 85: 3405-3411
    PubMedGoogle Scholar
  • 79 Rosing J, Hoekema L, Nicolaes GAF, Thomassen MCLGD, Hemker HC, Varadi K, Schwarz HP, Tans G. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem 1995; 270: 27852-27858
    CrossrefPubMedGoogle Scholar
  • 80 Aparicio C, Dahlbäck B. Molecular mechanisms of activated protein C resistance. Properties of factor V isolated from an individual with homozygosity for the Arg506 to Gin mutation in the factor V gene. Biochem J 1996; 313: 467-472
    CrossrefPubMedGoogle Scholar
  • 81 Nesheim ME, Canfield WM, Kisiel W, Mann KG. Studies of the capacity of factor Xa to protect factor Va from inactivation by activated protein C. J Biol Chem 1982; 257: 1443-1447
    PubMedGoogle Scholar
  • 82 Heeb MJ, Mesters RM, Tans G, Rosing J, Griffin JH. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. J Biol Chem 1993; 268: 2872-2877
    PubMedGoogle Scholar
  • 83 Heeb MJ, Rosing J, Bakker HM, Fernandez JA, Tans G, Griffin JH. Protein S binds to and inhibits factor Xa. Proc Natl Acad Sci USA 1994; 91: 2728-2732
    CrossrefPubMedGoogle Scholar
  • 84 Dahlbäck B, Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci USA 1994; 91: 1396-1400
    CrossrefPubMedGoogle Scholar
  • 85 Shen L, Dahlbäck B. Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa. J Biol Chem 1994; 269: 18735-18738
    PubMedGoogle Scholar
  • 86 Lu D, Kalafatis M, Mann KG, Long GL. Comparison of activated protein C/protein S-mediated inactivation of human factor VIII and factor V. Blood 1996; 87: 4708-4717
    PubMedGoogle Scholar
  • 87 Varadi K, Rosing J, Tans G, Pabinger I, Keil B, Schwarz HP. Factor V enhances the cofactor function of protein S in the APC- mediated inactivation of factor VIII: influence of the factor VR506Q mutation. Thromb Haemostas 1996; 76 (02) 208-214
    PubMedGoogle Scholar
  • 88 Walker FJ, Chavin SI, Fay PJ. Inactivation of factor VIII by activated protein C and protein S. Arch Biochem Biophys 1987; 252: 322-328
    CrossrefPubMedGoogle Scholar
  • 89 Fay PH, Smudzin TM, Walker FJ. Activated protein C-catalyzed inactivation of human factor VIII and factor VIIIa. J Biol Chem 1991; 266: 20139-20145
    PubMedGoogle Scholar